Related Experiment Video
Updated: Mar 24, 2026

05:50
Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
4.9K
[MORPHOLOGICAL CHANGES OF GASTRIC MUCOSA AFTER INSERTION OF INTRAGASTRIC BALLOON].
Klinichna Khirurhiia
|March 8, 2016
Summary
Intragastric balloons (IGB) can cause significant gastric inflammation, requiring at least 14 days for mucosal normalization post-removal. Bariatric surgery should be scheduled after this recovery period to ensure optimal outcomes.
Area of Science:
- Gastroenterology and Bariatric Surgery
- Histopathology and Endoscopic Evaluation
- Medical Device Impact on Gastric Mucosa
Context:
- Obesity management often involves bariatric procedures.
- Intragastric balloons (IGB) are a temporary measure preceding bariatric surgery.
- Understanding gastric mucosal response to IGB is crucial for surgical timing.
Purpose:
- To investigate morphological changes in gastric mucosa following intragastric balloon (IGB) insertion.
- To determine the optimal timing for bariatric operations after IGB removal.
- To assess the reversibility of IGB-induced gastropathy.
Summary:
- Histological examination revealed chronic gastritis in 64.3% of patients before IGB insertion.
- Endoscopic and histological data post-IGB removal showed significant inflammation, including erythematous and erosive gastropathy.
- Gastric mucosa normalization occurred within 14 days after IGB removal, indicating a need for delayed bariatric intervention.
Impact:
- Establishes a critical post-IGB recovery window for bariatric surgery scheduling.
- Highlights the inflammatory potential of IGB on gastric mucosa.
- Provides evidence-based recommendations for patient management pathways in bariatric care.
More Related Videos
Related Concept Videos
Mucosal Barrier of the Stomach
2.8K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.8K
Gross Anatomy of the Stomach
3.9K
The human stomach is a vital part of the digestive system, performing multiple functions. It is located within the peritoneum, a serous membrane that lines the abdominal cavity. The stomach plays a central role in processing food substances and interacts with other digestive organs through coordinated digestive processes. The stomach has a characteristic J-shape and is divided into four main regions. The cardia is the first section where the esophagus connects to the stomach and is the entry...
3.9K
Gastritis-I: Introduction and Types
3.2K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
3.2K
Gastritis-II: Pathophysiology
1.7K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.7K
Stomach Histology
3.7K
The stomach comprises several layers that work together to facilitate digestion and protect the organ. The outermost layer is called the serosa, which provides support and protection to the stomach. The muscularis externa layer is responsible for the mechanical breakdown of food by contracting and moving the stomach. The submucosa layer, located beneath the muscularis externa, contains connective tissue, blood vessels, nerves, and glands that secrete mucus and other substances essential for...
3.7K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
766
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
766

